chikungunya-virus

Documents about chikungunya-virus

• Trial of an Inactivated Chikungunya Virus Vaccine#123551ClinicalTrials.gov
• A Phase I Study of PepGNP-ChikV in Healthy Volunteers#387221ClinicalTrials.gov
• Post-chikungunya chronic arthralgia in Burkina Faso: Frequency and associated factors#127897PLOS
• Chikungunya virus in dengue-suspected patients: Molecular evidence from the 2019 outbreak in Yangon, Myanmar#152675PLOS
• Chikungunya Virus Detection in Semen#865075ClinicalTrials.gov
• Socio-environmental assessment of <i>Aedes aegypti</i> distribution and risk of chikungunya in vulnerable community#1313610PLOS
• Chikungunya Virus Vaccine Trial in Healthy Adults#180224ClinicalTrials.gov
• Chikungunya virus at a crossroads: Emergence, interventions, and global health strategies.#13867PubMed
• Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)#435767ClinicalTrials.gov
• Characterization and control of emerging viral diseases in Cambodia : insights from bat coronaviruses and chikungunya virus#333872HAL (France)
• Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults#829624ClinicalTrials.gov
• Producción científica mundial sobre el virus Chikungunya: Análisis bibliométrico de su evolución y tendencias temáticas 2015–2025#265764Repositorio Institucional de la Universidad Señor de Sipán
• Consequences of a Maternal-fetal Chikungunya Virus Infection#1093763ClinicalTrials.gov
• Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults#898874ClinicalTrials.gov
• Against Chikungunya Virus and Neonatal Infection#1087295ClinicalTrials.gov
• RT-PCR on Urine Samples: Added Value for the Diagnosis of Chikungunya Virus Infection#862921ClinicalTrials.gov
• Research advances in chikungunya virus: Epidemiology, pathogenesis, and control#123294Europe PMC
• Cohort of Patients Infected by an Arbovirus#1446403ClinicalTrials.gov
• Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)#914254ClinicalTrials.gov
• Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006)#127660ClinicalTrials.gov
• Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults#261348ClinicalTrials.gov
• Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine#897913ClinicalTrials.gov
• Utility of sentinel surveillance as an early warning system for emerging pathogens in a low-resource setting: Correlations of dengue, chikungunya, Zika, and COVID-19 trends between sentinel and passive surveillance systems in Puerto Rico, 2012–2023#275938PLOS
• Chikungunya virus nsP2: Insights into viral replication, pathogenesis, and therapeutic targeting#231375Europe PMC
• Potencial terapêutico da silimarina na artrite e miosite induzidas pelos vírus Chikungunya e Mayaro.#434686REPOSITORIO INSTITUCIONAL DA UFOP
• Avaliação da atividade antiviral de Byrsonima aerugo contra o vírus Chikungunya.#446807REPOSITORIO INSTITUCIONAL DA UFOP
• Overview of chikungunya viral transmission, French Guiana, 2026#268489HAL (France)
• Safety and Immunogenicity of a Candidate CHIKV Vaccine (CHIK001)#914484ClinicalTrials.gov
• Synthesis, screening and validation of cysteine-reactive fragments as chikungunya virus protease inhibitors#368421Open Research
• Safety, Tolerability, and Immunogenicity of VAL-181388 in Healthy Participants#859818ClinicalTrials.gov
• Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil#1323528ClinicalTrials.gov
• WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever#129089WHO IRIS
• Direct RNA Sequencing of Dengue and Chikungunya Viruses with Ultra-Low Input and Custom Multiplexing#326280HAL (France)
• Impact of climate change on the global circulation of chikungunya virus: current evidence, future projections, and adaptation strategies#642521Europe PMC
• Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia#1464226ClinicalTrials.gov
• A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.#454074ClinicalTrials.gov
• ZIKAlliance Natural History Study#1074976ClinicalTrials.gov
• Effects of a single mutation in Chikungunya virus non-structural protein on virus infection in Aedes Albopictus and Mammalian Cell Lines#1360815UM Research Repository
• Inhibiting Chikungunya Virus Protease using MTase-like Domain Interactions for Novel Antiviral Therapies#675278DigitalCommons@USU
• A Clinical Phase 3 Trial of VLA1553 in Adult Participants with Human Immunodeficiency Virus (HIV)#435785ClinicalTrials.gov
• Seroprevalence of Chikungunya at the End of the First Chikungunya Outbreak in the French Antilles Within a Sample of Patients Treated for a HIV Infection#904862ClinicalTrials.gov
• An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults#1451892ClinicalTrials.gov
• Maternal Chikungunya virus infection and pregnancy outcomes: a global systematic review and meta-analysis of vertical transmission dynamics and associated morbidity#125747Europe PMC
• Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults#640454ClinicalTrials.gov
• A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.#651121ClinicalTrials.gov
• Avaliação da potencial atividade antiviral de uma nanoemulsão de óleo de Copaifera sp. (Copaíba) contra o vírus chikungunya#320859RI UFPE
• Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years#154729ClinicalTrials.gov
• Computational identification of potential inhibitors for chikungunya virus nsP2pro.#1236368NCBI PubMed Central
• Dengue and chikungunya virus transmission in Kinshasa, Democratic Republic of the Congo#381668bioRxiv / medRxiv
• Real-world Effectiveness, Safety and Immunogenicity of Chikungunya Vaccination in Populations at Risk of Severe or Complicated Forms: Prospective Study in La Réunion#136407ClinicalTrials.gov